Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Simcere Pharmaceutical Group Limited ( (HK:2096) ) is now available.
Simcere Pharmaceutical Group has announced a change in its senior corporate governance team, with joint company secretary Ms. Wong Wai Ling resigning effective March 25, 2026, and confirming she has no disagreements with the board or issues requiring shareholder attention. The board has appointed Ms. Mak Po Man Cherie, a seasoned governance and accounting professional, as the new joint company secretary alongside existing joint company secretary and chief financial officer Mr. Wan Yushan, underscoring the company’s focus on maintaining strong compliance and governance capabilities.
Ms. Mak brings over 20 years of experience in audit, accounting, corporate finance, compliance and corporate secretarial work, and holds professional memberships in key governance and accounting institutes, enhancing the company’s governance expertise. Mr. Wan, who continues as executive director, CFO and joint company secretary with more than two decades at the group, provides continuity in financial and compliance oversight, signaling stability in Simcere’s management structure and ongoing adherence to Hong Kong listing requirements.
The most recent analyst rating on (HK:2096) stock is a Buy with a HK$16.30 price target. To see the full list of analyst forecasts on Simcere Pharmaceutical Group Limited stock, see the HK:2096 Stock Forecast page.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a Hong Kong–incorporated pharmaceutical company listed on the Stock Exchange of Hong Kong. The group focuses on developing, manufacturing and commercializing pharmaceutical products, with operations supported by dedicated financial, legal, compliance and corporate governance functions across its subsidiaries.
Average Trading Volume: 6,403,851
Technical Sentiment Signal: Buy
Current Market Cap: HK$28.76B
For an in-depth examination of 2096 stock, go to TipRanks’ Overview page.